Black Diamond Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -8.90M-28.87M-65.53M-123.41M
Depreciation and Depletion 0.04M0.05M0.05M0.20M0.51M0.44M0.34M
Share-based Compensation 0.06M3.64M7.76M14.04M12.20M9.60M10.63M
Gains from Investment Securities 0.00M0.05M8.47M-0.09M-0.02M0.25M
Cash from Operations -8.45M-24.67M-52.15M-100.15M-85.08M-66.72M-62.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.73M2.19M-0.54M1.17M3.78M
Depreciation & Amortization (CF) 0.04M0.05M0.05M0.20M0.51M0.44M0.34M
Change in Working Capital
Change in Account Payables 0.26M1.45M1.07M1.57M-2.23M0.60M1.68M
Change in Accured Expenses 0.29M1.79M8.03M8.71M-5.86M3.94M-0.76M
Other Working Capital Changes -0.01M1.02M3.44M-1.73M-2.84M-3.11M-3.40M
Investing Activities
Capital Expenditures 0.08M0.02M0.14M2.71M0.19M0.03M
Sales of Property, Plant and Equipment 0.01M0.10M0.09M
Change in Acquisitions & Divestments 90.93M182.83M113.69M78.17M139.75M
Cash from Investing Activities -0.08M-0.02M-281.69M130.61M53.37M16.35M16.97M
Financing Activities
Other financing activities 1.74M
Cash from Financing Activities 52.31M127.76M214.94M0.73M0.18M71.93M25.55M
Additional items
Change in Cash 43.78M103.06M-118.89M31.19M-31.54M21.56M-19.79M
Free Cash Flow -8.53M-24.70M-52.29M-102.86M-85.27M-66.75M-62.30M
Net Cash Flow 43.78M103.06M-118.89M31.19M-31.54M21.56M-19.79M